Zhangzhou Hospital, Fujian Province
Zhangzhou Hospital, Fujian Province
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial | Capecitabine; Local Advanced Rectal Cancer; Oxaliplatin; PCSK9 Inhibitor; PD-1 Inhibitor; RCT; Radiotherapy | Not yet recruiting | Phase 3 | 2026-07-07 | NCT07686796 |